West Pharma (WST) Reports Q3 EPS of $0.44

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. SPCX
9. WDC
10. MRK

Go back to West Pharma (WST) Reports Q3 EPS of $0.44

West Announces Third Quarter 2015 Results

October 29, 2015 7:01 AM EDT

EXTON, PA -- (Marketwired) -- 10/29/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2015 and updated financial guidance for the full year 2015.

Executive Summary

Third quarter 2015 reported sales of $344.5 million were 3.2% below prior-year sales. Net sales at constant currency grew by 5.2% as foreign currency translation reduced reported sales by over 8%. Gross margin improves year-over-year on growth in high-value pharmaceutical packaging sales. Third quarter reported diluted EPS was $0.02. Adjusted diluted EPS of $0.44 excludes a $0.42 non-cash pension-settlement charge. EPS comparisons to the... More